Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Us...

Descripción completa

Detalles Bibliográficos
Autores principales: Addeo, Alfredo, Shah, Pankil K., Bordry, Natacha, Hudson, Robert D., Albracht, Brenna, Di Marco, Mariagrazia, Kaklamani, Virginia, Dietrich, Pierre-Yves, Taylor, Barbara S., Simand, Pierre-Francois, Patel, Darpan, Wang, Jing, Labidi-Galy, Intidhar, Fertani, Sara, Leach, Robin J., Sandoval, Jose, Mesa, Ruben, Lathrop, Kate, Mach, Nicolas, Shah, Dimpy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218532/
https://www.ncbi.nlm.nih.gov/pubmed/34214473
http://dx.doi.org/10.1016/j.ccell.2021.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218532/
https://www.ncbi.nlm.nih.gov/pubmed/34214473
http://dx.doi.org/10.1016/j.ccell.2021.06.009

Ejemplares similares